LEADER 05476nam 2200637Ia 450 001 9910457358603321 005 20200520144314.0 010 $a1-281-04773-2 010 $a9786611047733 010 $a0-08-053783-9 035 $a(CKB)1000000000350778 035 $a(EBL)314009 035 $a(OCoLC)476105296 035 $a(SSID)ssj0000212745 035 $a(PQKBManifestationID)12030317 035 $a(PQKBTitleCode)TC0000212745 035 $a(PQKBWorkID)10138267 035 $a(PQKB)10161672 035 $a(MiAaPQ)EBC314009 035 $a(Au-PeEL)EBL314009 035 $a(CaPaEBR)ebr10191625 035 $a(CaONFJC)MIL104773 035 $a(EXLCZ)991000000000350778 100 $a19991006d2000 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aNucleation$b[electronic resource] $ebasic theory with applications /$fDimo Kashchiev 210 $aOxford ;$aBoston $cButterworth-Heinemann$d2000 215 $a1 online resource (551 p.) 300 $aDescription based upon print version of record. 311 $a0-7506-4682-9 320 $aIncludes bibliographical references (p. [495]-513) and indexes. 327 $aFront Cover; Nucleation: Basic Theory with Applications; Copyright Page; Contents; Preface; Symbols and abbreviations; Part 1: Thermodynamics of nucleation; Chapter 1. First-order phase transitions; Chapter 2. Driving force for nucleation; Chapter 3. Work for cluster formation; 3.1 Homogeneous nucleation; 3.2 Heterogeneous nucleation; 3.3 General formulae; 3.4 Absence of one-dimensional nucleation; Chapter 4. Nucleus size and nucleation work; 4.1 General formulae; 4.2 Homogeneous nucleation; 4.3 Heterogeneous nucleation; 4.4 Atomistically small nuclei; Chapter 5. Nucleation theorem 327 $a5.1 Phenomenological proof 5.2 Thermodynamic proof; 5.3 Generalizations; 5.4 Integral form; Chapter 6. Properties of clusters; 6.1 Inside pressure; 6.2 Chemical potential; 6.3 Vapour pressure; 6.4 Solubility; 6.5 Melting point; 6.6 Specific surface energy; Chapter 7. Equilibrium cluster size distribution; 7.1 Equilibrium concentration of clusters; 7.2 Equilibrium concentration of nuclei; Chapter 8. Density-functional approach; 8.1 General considerations; 8.2 Gradient approximation; 8.3 Hard-sphere approximation; 8.4 Quasi-thermodynamics; 8.5 Quasi-thermodynamic formulation 327 $aPart 2: Kinetics of nucleation Chapter 9. Master equation; 9.1 General formulation; 9.2 Nucleation stage; 9.3 Coalescence stage; 9.4 Ageing stage; Chapter 10. Transition frequencies; 10.1 Monomer attachment frequency; 10.2 Monomer detachment frequency; 10.3 Multimer attachment frequency; 10.4 Multimer detachment frequency; 10.5 General formulae; Chapter 11. Nucleation rate; Chapter 12. Equilibrium; Chapter 13. Stationary nucleation; 13.1 Stationary cluster size distribution; 13.2 Stationary rate of nucleation; 13.3 Particular cases; 13.4 Concentration of supernucle i 327 $a13.5 Comparison with experiment Chapter 14. First application of the nucleation theorem; Chapter 15. Non-stationary nucleation; 15.1 Non-stationary cluster size distribution; 15.2 Non-stationary rate of nucleation; 15.3 Time lag of nucleation; 15.4 Delay time of nucleation; 15.5 Concentration of supernuclei; 15.6 Suggestion; 15.7 Finding the equilibrium concentration of nuclei; Chapter 16. Second application of the nucleation theorem; Chapter 17. Nucleation at variable supersaturation; 17.1 Quasi-stationary cluster size distribution; 17.2 Quasi-stationary rate of nucleation 327 $a17.3 Condition for quasi-stationarity Part 3: Factors affecting nucleation; Chapter 18. Seed size; Chapter 19. Line energy; Chapter 20. Strain energy; Chapter 21. Electric field; 21.1 General formulae; 21.2 Nucleation on ions; 21.3 Nucleation in external electric field; Chapter 22. Carrier-gas pressure; Chapter 23. Solution pressure; Chapter 24. Pre-existing clusters; 24.1 Non-stationary cluster size distribution; 24.2 Non-stationary rate of nucleation; 24.3 Concentration of supernuclei; 24.4 Delay time of nucleation; Chapter 25. Active centres; Part 4: Applications 327 $aChapter 26. Overall crystallization 330 $aThis book represents a detailed and systematic account of the basic principles, developments and applications of the theory of nucleation.The formation of new phases begins with the process of nucleation and is, therefore, a widely spread phenomenon in both nature and technology. Condensation and evaporation, crystal growth, electrodeposition, melt crystallization, growth of thin films for microelectronics, volcano eruption and formation of particulate matter in space are only a few of the processes in which nucleation plays a prominent role.The book has four parts, which a 606 $aNucleation 606 $aChemistry, Physical and theoretical 608 $aElectronic books. 615 0$aNucleation. 615 0$aChemistry, Physical and theoretical. 676 $a548.5 700 $aKashchiev$b Dimo$0312237 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910457358603321 996 $aNucleation$9718692 997 $aUNINA LEADER 02085nam 2200469 450 001 9910461000703321 005 20200520144314.0 010 $a1-4438-8396-4 035 $a(CKB)3710000000517413 035 $a(EBL)4534868 035 $a(MiAaPQ)EBC4534868 035 $a(Au-PeEL)EBL4534868 035 $a(CaPaEBR)ebr11215881 035 $a(CaONFJC)MIL838930 035 $a(OCoLC)925304485 035 $a(EXLCZ)993710000000517413 100 $a20160619h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aAverting a global environmental collapse $ethe role of anthropology and local knowledge /$fedited by Thomas Reuter 210 1$aNewcastle upon Tyne, England :$cCambridge Scholars Publishing,$d2015. 210 4$d©2015 215 $a1 online resource (272 p.) 300 $aDescription based upon print version of record. 311 $a1-4438-7597-X 320 $aIncludes bibliographical references at the end of each chapters and index. 330 $aThe numerous and varied indicators of environmental risks point toward the likelihood of a systemic and catastrophic ecological failure at some point during this century. Political inaction and cultural resistance, meanwhile, are even preventing the implementation of already available technical solutions, which has led many experts to conclude that averting a global environmental catastrophe is, foremost, a socio-political, rather than a technical, challenge. The World Science Union (ICSU) has recognized that knowledge of the social sciences is indispensable for facilitating the major socio-cu 606 $aEnvironmental degradation$xSocial aspects 608 $aElectronic books. 615 0$aEnvironmental degradation$xSocial aspects. 676 $a333.7137 702 $aReuter$b Thomas 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910461000703321 996 $aAverting a global environmental collapse$91947625 997 $aUNINA LEADER 03887nam 22005894a 450 001 9910456496003321 005 20170814171550.0 010 $a1-282-54358-X 010 $a9786612543586 010 $a0-19-971340-5 035 $a(CKB)2550000000010662 035 $a(SSID)ssj0000399984 035 $a(PQKBManifestationID)12170606 035 $a(PQKBTitleCode)TC0000399984 035 $a(PQKBWorkID)10393780 035 $a(PQKB)10411406 035 $a(MiAaPQ)EBC2012777 035 $a(EXLCZ)992550000000010662 100 $a20080625d2010 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDiabetes and ocular disease$b[electronic resource] $epast, present, and future therapies /$fedited by Ingrid U. Scott, Harry W. Flynn, Jr., William E. Smiddy 205 $a2nd ed. 210 $aOxford ;$aNew York $cOxford University Press in cooperation with the American Academy of Ophthalmology$dc2010 215 $axv, 496 p. $cill. (some col.), col. maps 225 1 $aOphthalmology monographs ;$v14 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-19-534023-X 320 $aIncludes bibliographical references and index. 327 $aMedical overview of the worldwide diabetes epidemic / Robert E. Leonard II and David W. Parke II -- Classification of diabetic retinopathy / Charles P. Wilkinson -- Histopathology of diabetic retinopathy / Matthew Guess and Sander R. Dubovy -- Pathogenesis of diabetic retinopathy / Thomas W. Gardner and Lloyd Paul Aiello -- Epidemiology and risk factors of diabetic retinopathy / Tien Y. Wong, Ronald Klein, and Barbara E.K. Klein -- History of evolving treatments for diabetic retinopathy / George W. Blankenship -- Photography, angiography, and ultrasonography in diabetic retinopathy / Andrew Lam ... [et al.] -- Optical coherence tomography in the management of diabetic retinopathy / Andrew A. Moshfeghi ... [et al.] -- Clinical studies on treatment for diabetic retinopathy / Frederick L. Ferris III ... [et al.] -- Photocoagulation for diabetic macular edema and diabetic retinopathy / Mitchell J. Goff, H. Richard McDonald, and Everett Ai -- Vitrectomy for diabetic retinopathy / William E. Smiddy and Harry W. Flynn, Jr. -- Intravitreal pharmacotherapies for diabetic retinopathy / Sophie J. Bakri and Peter K. Kaiser -- 327 $aEvolving algorithms for managing diabetic macular edema / Diana V. Do and Julia A. Haller -- Management of diabetic retinopathy : evidence-based systematic review / Quresh Mohamed and Tien Y. Wong -- Cataract management in diabetes / Mitchell S. Fineman, William E. Benson, and Ingrid U. Scott -- Nonretinal ocular abnormalities in diabetes / Ingrid U. Scott and Harry W. Flynn, Jr. -- The effect of systemic conditions on diabetic retinopathy / Emily Y. Chew -- Medical management of the diabetic patient / Jay S. Skyler -- Telemedicine for diabetic retinopathy / Helen K. Li and Matthew T.S. Tennant -- Future therapies : rationale for and status of antiangiogenic and antipermeability interventions / Nigel H. Timothy ... [et al.] -- Abstracts of major collaborative multicenter trials for diabetic retinopathy / compiled by Ingrid U. Scott, Nauman A. Chaudhry, and Harry W. Flynn, Jr. 410 0$aOphthalmology monographs ;$v14. 606 $aDiabetic retinopathy 606 $aCataract 608 $aElectronic books. 615 0$aDiabetic retinopathy. 615 0$aCataract. 676 $a617.7/35 701 $aScott$b Ingrid U$0899527 701 $aFlynn$b Harry W$0899528 701 $aSmiddy$b William E$0899529 712 02$aAmerican Academy of Ophthalmology. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910456496003321 996 $aDiabetes and ocular disease$92009912 997 $aUNINA LEADER 04929nam 2201249z- 450 001 9910557285803321 005 20210501 035 $a(CKB)5400000000041182 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69137 035 $a(oapen)doab69137 035 $a(EXLCZ)995400000000041182 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNonequilibrium Phenomena in Strongly Correlated Systems 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (264 p.) 311 08$a3-03936-814-1 311 08$a3-03936-815-X 330 $aThe book is devoted to the fundamental aspects of the non-equilibrium statistical mechanics of many-particle systems. The concept of Zubarev's approach, which generalizes the notion of Gibbs' ensembles, and introduces a nonequilibrium statistical operator, providing an adequate basis for dealing with strongly correlated systems that are governed by nonperturbative phenomena, such as the formation of bound states, quantum condensates and the instability of the vacuum. Besides a general introduction to the formalism, this book contains contributions devoted to the applications of Zubarev's method to the solution of modern problems in different fields of physics: transport theory, hydrodynamics, high-energy physics, quark-gluon plasma and hadron production in heavy-ion collisions. The book provides valuable information for researchers and students in these fields, requiring powerful concepts to solve fundamental problems of non-equilibrium phenomena in strongly 606 $aResearch & information: general$2bicssc 610 $aacceleration 610 $aALICE 610 $aBogoliubov's quasi-averages 610 $aBoltzmann equation 610 $aBose-Einstein condensate 610 $abound states 610 $acorrelation functions 610 $acritical point 610 $adimensional renormalization 610 $adynamic correlations 610 $adynamic critical phenomena 610 $aelectrical conductivity 610 $aentropy 610 $afinite temperature field theory 610 $afinite-time-path formalism 610 $aFokker-Planck equation 610 $aGibbs equilibrium statistical mechanics 610 $agluon saturation 610 $agluons 610 $agraphene 610 $ahadronization 610 $ahigh-field and nonlinear effects 610 $ahydrodynamics 610 $ainterband transitions 610 $airreversibility 610 $akinetic equations 610 $akinetic theory 610 $akinetics 610 $aKubo formulae 610 $aLHC 610 $alinear response theory 610 $alow density approximation 610 $amaster equation 610 $anon-equilibrium states 610 $anon-equilibrium statistical operator 610 $anonequilibrium thermo-field dynamics 610 $aopen quantum system 610 $aordered lattice, disordered lattice 610 $aout-of-equilibrium quantum field theory 610 $aparticle production 610 $apath integrals 610 $apermittivity, dynamical conductivity, absorption coefficient, dynamical collision frequency 610 $aphase transition 610 $apion chemical potential 610 $apion enhancement 610 $apressure fluctuations 610 $aQCD 610 $aQCD matter 610 $aquantum anomalies 610 $aquantum fields in curved spacetime 610 $aquantum statistical mechanics 610 $aquark-gluon plasma 610 $aquasi-temperature 610 $arelativistic fluid dynamics 610 $arelativistic hydrodynamics 610 $arelativistic ideal gas 610 $arelaxation time approximation 610 $arelevant statistical operator 610 $aSchwinger effect 610 $astatistical operator 610 $asymmetries 610 $athermalization 610 $atransport coefficients 610 $aUmklapp process 610 $aUnruh effect 610 $aZitterbewegung 610 $aZubarev formalism 610 $aZubarev operator 615 7$aResearch & information: general 700 $aBlaschke$b David$4edt$066152 702 $aFriesen$b Alexandra$4edt 702 $aMorozov$b Vladimir$4edt 702 $aPlakida$b Nikolay$4edt 702 $aRöpke$b Gerd$4edt 702 $aBlaschke$b David$4oth 702 $aFriesen$b Alexandra$4oth 702 $aMorozov$b Vladimir$4oth 702 $aPlakida$b Nikolay$4oth 702 $aRöpke$b Gerd$4oth 906 $aBOOK 912 $a9910557285803321 996 $aNonequilibrium Phenomena in Strongly Correlated Systems$93018442 997 $aUNINA LEADER 03552nam 22006735 450 001 9910300096803321 005 20251117071625.0 010 $a1-4471-5472-X 024 7 $a10.1007/978-1-4471-5472-3 035 $a(CKB)3710000000073724 035 $a(EBL)1592860 035 $a(SSID)ssj0001067244 035 $a(PQKBManifestationID)11612776 035 $a(PQKBTitleCode)TC0001067244 035 $a(PQKBWorkID)11097044 035 $a(PQKB)10554283 035 $a(MiAaPQ)EBC1592860 035 $a(DE-He213)978-1-4471-5472-3 035 $a(PPN)176096949 035 $a(EXLCZ)993710000000073724 100 $a20131121d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCardiac Drugs in Pregnancy /$fedited by Karen Sliwa, John Anthony 205 $a1st ed. 2014. 210 1$aLondon :$cSpringer London :$cImprint: Springer,$d2014. 215 $a1 online resource (141 p.) 225 1 $aCurrent Cardiovascular Therapy 300 $aDescription based upon print version of record. 311 08$a1-4471-5471-1 327 $aIntroduction -- General principles and guidelines -- Management of Hypertension -- Management of Heart Failure -- Management of  coronary artery disease & Arrhythmia -- Anticoagulation in Pregnancy -- Obstetric drugs in management if Cardiovascular disease -- Pregnancy anaesthesia in patients with cardiovascular disease. 330 $aIn the western world, the risk of cardiovascular disease in pregnancy has grown due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading to early diabetes and hypertension. As a result more women are requiring drug therapy during pregnancy  and some data has shown an altered pharmacodynamic profile in pregnant women when compared to the non-pregnant population. Cardiac Drugs in Pregnancy presents up-to-date research for the treatment of cardiovascular disease during pregnancy, and  discusses the most important indications of drug usage in pregnancy and postpartum. The book aims to assess the potential risk of drugs and their possible benefit against each other, making it an essential read for a wide range of health professionals involved in cardiac drug therapy in pregnancy. 410 0$aCurrent Cardiovascular Therapy 606 $aCardiology 606 $aObstetrics 606 $aMaternal and child health services 606 $aChemotherapy 606 $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037 606 $aObstetrics/Perinatology/Midwifery$3https://scigraph.springernature.com/ontologies/product-market-codes/H26014 606 $aMaternal and Child Health$3https://scigraph.springernature.com/ontologies/product-market-codes/H27025 606 $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000 615 0$aCardiology. 615 0$aObstetrics. 615 0$aMaternal and child health services. 615 0$aChemotherapy. 615 14$aCardiology. 615 24$aObstetrics/Perinatology/Midwifery. 615 24$aMaternal and Child Health. 615 24$aPharmacotherapy. 676 $a616.1061 702 $aSliwa$b Karen$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aAnthony$b John$c(Professor of obstetrics and gynecology)$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300096803321 996 $aCardiac Drugs in Pregnancy$91522055 997 $aUNINA